Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche Gets Priority Review for Avastin Label Expansion
Yahoo/Zacks.com
Wednesday, July 16, 2014 - 5:18pm
tags:
Roche, Avastin, cervical cancer
Pfizer Announces Purchase of InnoPharma for $225M Upfront Payment, Will Pay Up to $135M in Contingent Milestone Payments
Benzinga
Wednesday, July 16, 2014 - 11:21am
tags:
Pfizer, InnoPharma, M&A
J&J's new fixer turns consumer division back into a profit center
Fierce Pharma
Wednesday, July 16, 2014 - 11:11am
tags:
JNJ, consumer health
Impax Labs get subpoena in price fixing probe
Yahoo/Reuters
Wednesday, July 16, 2014 - 11:05am
tags:
Impax Labs, price fixing, generics, Digoxin, Connecticut
Shire Falls on Concern U.S. May Block Tax Inversions
Bloomberg
Wednesday, July 16, 2014 - 10:52am
tags:
Shire, tax inversions, M&A, AbbVie
AntriaBio Presents Vast Upside With Disruptive Once-Weekly Insulin
Seeking Alpha
Wednesday, July 16, 2014 - 10:47am
tags:
AntriaBio, insulin, AB101
Ackman urges Allergan talks with Valeant, no delay to special meeting
Yahoo/Reuters
Wednesday, July 16, 2014 - 10:44am
tags:
Bill Ackman, Allergan, Valeant Pharmaceuticals, M&A
Rigel Pharmaceuticals initiates Phase 3 studies of fostamatinib in ITP
Yahoo/Fly on the Wall
Wednesday, July 16, 2014 - 10:42am
tags:
fostamatinib, Rigel Pharmaceuticals, ITP
A Plan For Big Pharma Involvement In Superbug R&D
Forbes
Wednesday, July 16, 2014 - 10:40am
tags:
Big Pharma, R&D, superbugs, antibiotic resistance
Eli Lilly joins forces with UK biotech to develop cancer drugs
FT.com
Wednesday, July 16, 2014 - 10:39am
tags:
Eli Lilly, UK, Immunocore, R&D, cancer
OncoMed initiates Phase 2 ALPINE trial of tarextumab
Yahoo/Fly on the Wall
Wednesday, July 16, 2014 - 10:38am
tags:
OncoMed, tarextumab, pancreatic cancer, Abraxane
4 Top Biotechs Expected to Beat Earnings Expectations
24/7 Wall St
Wednesday, July 16, 2014 - 10:36am
tags:
earnings, Amgen, Gilead Sciences, Pharmacyclics, Seattle Genetics
Gilead Sciences: How Good Will Earnings Be?
Barron's
Wednesday, July 16, 2014 - 10:35am
tags:
Gilead Sciences, earnings
Pfizer says clotting drug's once-weekly dose reduces bleeding rate
Yahoo/Reuters
Wednesday, July 16, 2014 - 10:20am
tags:
Pfizer, BeneFix, hemophilia B
Pfizer: Struggling Through A Tough Time
Seeking Alpha
Wednesday, July 16, 2014 - 8:58am
tags:
Pfizer, China, Viagra, patents, Cellectis, oncology
St Jude Medical's quarterly profit doubles as expenses fall
Yahoo/Reuters
Wednesday, July 16, 2014 - 8:49am
tags:
earnings, devices, St. Jude Medical
Abbott Labs shares climb 2.7% as profit, sales top estimates
Marketwatch
Wednesday, July 16, 2014 - 8:47am
tags:
earnings, Abbott Labs
St. Jude pays $200 million for chronic pain device maker NeuroTherm
Yahoo/Zacks.com
Tuesday, July 15, 2014 - 2:06pm
tags:
St. Jude Medical, M&A, devices, chronic pain, NeuroTherm
Questcor's Own Data Blatantly Shows A 31% Decline In Net Sales Of Acthar By Aetna, With Other Insurers Following Suit - Mallinckrodt Shareholders, Pay Attention
Seeking Alpha
Tuesday, July 15, 2014 - 2:02pm
tags:
Questcor, Acthar, Mallinckrodt
Lilly Offers ‘Misleading’ Facts in our Patent Dispute, Says Canada
WSJ Online
Tuesday, July 15, 2014 - 11:49am
tags:
Eli Lilly, patents, Canada, Strattera, Zyprexa

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.